Bone morphogenetic protein 2 gene transduction enhances the osteogenic potential of human urine-derived stem cells

[1]  Changqing Zhang,et al.  Biological characteristics of human-urine-derived stem cells: potential for cell-based therapy in neurology. , 2014, Tissue engineering. Part A.

[2]  R. Barker,et al.  Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial , 2014, The Lancet.

[3]  B. Wang,et al.  BMP2 is Superior to BMP4 for Promoting Human Muscle-Derived Stem Cell-Mediated Bone Regeneration in a Critical-Sized Calvarial Defect Model , 2013, Cell transplantation.

[4]  V. Picanço-Castro,et al.  Advances in lentiviral vectors: a patent review. , 2012, Recent patents on DNA & gene sequences.

[5]  Mauro Giacca,et al.  Virus-mediated gene delivery for human gene therapy. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[6]  A. Tang,et al.  Repair of Critical‐Sized Rat Calvarial Defects Using Genetically Engineered Bone Marrow‐Derived Mesenchymal Stem Cells Overexpressing Hypoxia‐Inducible Factor‐1α , 2011, Stem cells.

[7]  Yan Liu,et al.  Human urine-derived stem cells seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue engineering. , 2011, Biomaterials.

[8]  A. Atala,et al.  Tissue-engineered conduit using urine-derived stem cells seeded bacterial cellulose polymer in urinary reconstruction and diversion. , 2010, Biomaterials.

[9]  G Gstraunthaler,et al.  Optimization of chemically defined cell culture media--replacing fetal bovine serum in mammalian in vitro methods. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[10]  Maryam Tabrizian,et al.  Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: Current challenges in BMP delivery , 2009, Biotechnology Letters.

[11]  Anthony Atala,et al.  Urine derived cells are a potential source for urological tissue reconstruction. , 2008, The Journal of urology.

[12]  Min Soo Bae,et al.  Enhancement of ectopic bone formation by bone morphogenetic protein-2 delivery using heparin-conjugated PLGA nanoparticles with transplantation of bone marrow-derived mesenchymal stem cells. , 2008, Journal of biomedical science.

[13]  Luis Apolonia,et al.  Stable gene transfer to muscle using non-integrating lentiviral vectors. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  Thomas A. Einhorn,et al.  Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery , 2007, International Orthopaedics.

[15]  W. Hsu,et al.  Lentiviral-mediated BMP-2 gene transfer enhances healing of segmental femoral defects in rats. , 2007, Bone.

[16]  Hidemi Kurihara,et al.  Behavior of transplanted bone marrow-derived mesenchymal stem cells in periodontal defects. , 2006, Journal of periodontology.

[17]  Yasuhiko Tabata,et al.  Enhanced ectopic bone formation using a combination of plasmid DNA impregnation into 3-D scaffold and bioreactor perfusion culture. , 2006, Biomaterials.

[18]  J. Dragoo,et al.  Tissue-Engineered Bone from BMP-2–Transduced Stem Cells Derived from Human Fat , 2005, Plastic and reconstructive surgery.

[19]  B. Feeley,et al.  Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[20]  G Gstraunthaler,et al.  The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[21]  H. Tsuda,et al.  Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  Johnny Huard,et al.  BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[23]  P. Robbins,et al.  The effect of bone morphogenetic protein-2 expression on the early fate of skeletal muscle-derived cells. , 2001, Bone.

[24]  K. Pluta,et al.  Use of HIV as a gene transfer vector. , 2009, Acta biochimica Polonica.

[25]  M. Harris,et al.  Bone tissue engineering and repair by gene therapy. , 2008, Frontiers in bioscience : a journal and virtual library.

[26]  K. Kraus,et al.  Fluorescently labeled mesenchymal stem cells (MSCs) maintain multilineage potential and can be detected following implantation into articular cartilage defects. , 2002, Biomaterials.

[27]  S. J. Wessman,et al.  Benefits and risks due to animal serum used in cell culture production. , 1999, Developments in biological standardization.

[28]  C. J. McGrath,et al.  Effect of exchange rate return on volatility spill-over across trading regions , 2012 .